Researchers have compiled a comprehensive list of 788 blood-based biomarkers studied over the past 5 years that could be used to develop early stage cancer screening tests.
Study finds women taking combined HRT can be up to 2.7 times more likely to develop breast cancer during the period of HRT use compared with women who had never received the therapy – highlighting underestimation of risk in previous studies.
Researchers have demonstrated that treating estrogen receptor-positive breast cancers with estrogen-deprivation therapy alters the array of mutations present in the tumor population.
In the face of conflicting clinical data, this Commentary article considers whether there remains a role for induction chemotherapy in the treatment of head and neck cancer.
This article from Epigenomics discusses the potential of DNA methylation patterns as both noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.